InspireMD (NSPR) CEO adds 21,000 shares in $1.20 open-market buy

Rhea-AI Filing Summary

InspireMD, Inc. CEO and President Marvin Slosman reported an open-market purchase of 21,000 shares of Common Stock at $1.20 per share. Following this transaction, he directly owns 3,556,658 InspireMD shares, indicating a modest increase in his personal stake in the company.

Insider Trade Summary

Net Buyer: 21,000 shares ($25,200)

Net Buy 1 txn

Insider Slosman Marvin

Role CEO and President

Bought 21,000 shs ($25K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	21,000	$1.20	$25K

Holdings After Transaction: Common Stock — 3,556,658 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 21,000 shares Purchase price: $1.20 per share Total holdings after trade: 3,556,658 shares +2 more

5 metrics

Shares purchased 21,000 shares Open-market purchase of Common Stock

Purchase price $1.20 per share Price paid in the reported transaction

Total holdings after trade 3,556,658 shares Direct ownership following the purchase

Transaction date 2026-05-12 Date of open-market purchase

Transaction code P Purchase in open market or private transaction

Key Terms

open-market purchase, Common Stock, Form 4, direct ownership

4 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

direct ownership financial

"ownership_type: "direct" and ownership_code: "D""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Slosman Marvin

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FLORIDA 33126

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/12/2026		P		21,000	A	$1.2	3,556,658	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Michael Lawless, Attorney-in-Fact for Marvin Slosman	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did InspireMD (NSPR) report on this Form 4?

InspireMD reported that CEO Marvin Slosman bought 21,000 shares of Common Stock. The open-market purchase occurred at a price of $1.20 per share, increasing his direct ownership position in the company.

How many InspireMD (NSPR) shares does CEO Marvin Slosman now hold?

After the reported transaction, CEO Marvin Slosman directly holds 3,556,658 InspireMD shares. This total reflects his position following the 21,000-share open-market purchase disclosed in the Form 4 filing.

At what price did the InspireMD (NSPR) CEO buy additional shares?

Marvin Slosman purchased 21,000 InspireMD Common Stock shares at $1.20 per share. This transaction was classified as an open-market purchase under code P in the Form 4 filing.

Was the InspireMD (NSPR) CEO transaction a buy or a sell?

The transaction was a buy. CEO Marvin Slosman executed an open-market purchase of 21,000 InspireMD Common Stock shares, as indicated by transaction code P and the buy classification in the Form 4 data.

Is the InspireMD (NSPR) CEO’s ownership direct or indirect after this trade?

The Form 4 shows Marvin Slosman’s ownership as direct after the transaction. The 3,556,658 shares reported following the trade are classified with a direct ownership code in the filing.